FDA Approvals - FDA Panel Votes Down NVS DrugAn FDA advisory panel recommended
FDA Panel Votes Down NVS Drug
An FDA advisory panel recommended against approving Novartis' pipeline candidate ACZ885 for the treatment of severe gouty arthritis.
« FDA: Do not eat Evergreen Produce brand alfalfa sprouts or | Main | Bedford Laboratories Statement Regarding Nationwide Voluntary Recall Of One Lot »